ICU Net Receivables from 2010 to 2024

ICUI Stock  USD 103.99  2.28  2.15%   
ICU Medical's Net Receivables is increasing with slightly volatile movements from year to year. Net Receivables is estimated to finish at about 172.5 M this year. For the period between 2010 and 2024, ICU Medical, Net Receivables quarterly trend regression had mean deviation of  67,499,908 and range of 220.9 M. View All Fundamentals
 
Net Receivables  
First Reported
1991-12-31
Previous Quarter
164.3 M
Current Value
169 M
Quarterly Volatility
72.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU main balance sheet or income statement drivers, such as Depreciation And Amortization of 263.2 M, Interest Expense of 142.1 M or Total Revenue of 2.4 B, as well as many exotic indicators such as Price To Sales Ratio of 1.01, Dividend Yield of 0.0 or PTB Ratio of 1.08. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.
  
This module can also supplement ICU Medical's financial leverage analysis and stock options assessment as well as various ICU Medical Technical models . Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

Latest ICU Medical's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of ICU Medical over the last few years. It is ICU Medical's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

ICU Net Receivables Regression Statistics

Arithmetic Mean113,522,913
Geometric Mean72,338,117
Coefficient Of Variation67.29
Mean Deviation67,499,908
Median105,894,000
Standard Deviation76,392,311
Sample Variance5835.8T
Range220.9M
R-Value0.77
Mean Square Error2542T
R-Squared0.60
Significance0.0008
Slope13,182,085
Total Sum of Squares81701T

ICU Net Receivables History

2024172.5 M
2023164.3 M
2022221.7 M
2021105.9 M
2020124.1 M
2019202.2 M
2018196.4 M

About ICU Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ICU Medical income statement, its balance sheet, and the statement of cash flows. ICU Medical investors use historical funamental indicators, such as ICU Medical's Net Receivables, to determine how well the company is positioned to perform in the future. Although ICU Medical investors may use each financial statement separately, they are all related. The changes in ICU Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ICU Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ICU Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ICU Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables164.3 M172.5 M

Currently Active Assets on Macroaxis

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for ICU Stock analysis

When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is ICU Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Earnings Share
(2.45)
Revenue Per Share
93.49
Quarterly Revenue Growth
(0)
Return On Assets
0.0048
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.